Previous 10 | Next 10 |
2023-09-26 04:57:50 ET Summary Sales of IC components, particularly for Cloud Data Center products, have contributed to SMTC's strong revenue and gross margin performance. Despite SMTC's strong 1H24 performance, caution is advised as industry peers express concerns about inventory...
2023-09-20 11:55:57 ET More on Health Care Sector: Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecutiv...
2023-09-13 08:59:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It makes sense to invest in autonomous driving stocks moving forward. Whether in September or any other month, the research is clear: The market is primed for growth boasting an annual growth...
2023-09-02 07:25:00 ET Ambarella 's (NASDAQ: AMBA) stock price plunged 20% on Aug. 30 after the image-processing chipmaker posted its latest earnings report. In the second quarter of fiscal 2024, which ended on July 31, its revenue fell 23% year over year to $62.1 million and missed...
2023-08-30 13:16:02 ET Gainers: NanoVibronix ( NAOV ) +127% . iCoreConnect ( ICCT ) +49% . Aravive ( ARAV ) +35% . AEON Biopharma ( AEON ) +33% . Alarum Technologies ( ALAR ) +25% . Greenland Technologies Holding Corporation ...
2023-08-30 13:03:54 ET More on Ambarella Ambarella: A Hold Going Into Earnings As We Look For Catalysts Ambarella: A Fragile Player In A Market Full Of Prospects Ambarella cut to Market Perform at TD Cowen Ambarella Non-GAAP EPS of -$0.15 beats by $0.03, reve...
2023-08-30 12:42:06 ET Semiconductor products from Ambarella (NASDAQ: AMBA) are used in Internet-of-Things (IoT) devices and cars, among other things. But right now, consumer demand is generally weak, and companies are trying to clean out old inventory, meaning they need fewer produ...
2023-08-30 08:52:44 ET More on Ambarella Ambarella: A Fragile Player In A Market Full Of Prospects Ambarella slumps ~20% after Q3 revenue outlook disappoints Seeking Alpha’s Quant Rating on Ambarella Earnings data for Ambarella For further deta...
2023-08-30 08:24:12 ET Outlook Therapeutics ( OTLK ) -78% . FibroGen ( FGEN ) -23% announces topline results from LELANTOS-2, a phase 3 clinical study of Pamrevlumab. Ambarella ( AMBA ) -20% after Q2 earning release . MasterCraft Boat Holdings (...
2023-08-30 06:17:55 ET More on Ambarella Ambarella: A Hold Going Into Earnings As We Look For Catalysts Ambarella: A Fragile Player In A Market Full Of Prospects Seeking Alpha’s Quant Rating on Ambarella Earnings data for Ambarella For further ...
News, Short Squeeze, Breakout and More Instantly...
HANGZHOU, China and SANTA CLARA, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Leapmotor (HKEX: 09863), a technology-driven intelligent electric vehicle company with a full suite of R&D capabilities, and Ambarella , Inc. (NASDAQ: AMBA), an edge AI semiconductor company, recently signed a ...
SANTA CLARA, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced financial results for its first quarter of fiscal year 2025 ended April 30, 2024. Revenue for the first quarter of fiscal 2025 was $54.5 million, down 12...